Articles tagged with Kinases
The Hawley Lab has identified two molecular mechanisms that restart the meiotic cycle in oocytes, including the controlled expression of Polo kinase and the inactivation of inhibitory protein Matrimony. This discovery has significant implications for understanding egg maturation and releasing, as well as treating infertility and cancer.
Researchers have identified two proteins controlling the pause in meiotic division, with Matrimony preventing Polo kinase from working until sufficient levels are reached. This work may lead to new treatments for infertility and cancer, as Polo kinase is strongly expressed in tumor cells.
Researchers at OHSU have identified the WNK kinase protein complex as a master switch that regulates blood pressure. The study reveals how this complex modulates salt and potassium balance in the kidney, raising or lowering blood pressure depending on its functioning.
A study published in JCI Journals reveals that disturbances in sphingolipid metabolism may be a key factor in early pregnancy loss. Sphingosine kinase 1 (Sphk1) and Sphk2 proteins play a crucial role in metabolizing these fats, which are essential for placental development.
A study published in PLOS ONE found that all eukaryotic kinases share a common set of substrates, suggesting that despite their diversity, these enzymes have similar functions. This discovery may improve the testing of drugs targeting protein kinases for various diseases.
Researchers at Rockefeller University have discovered a new therapeutic target, casein kinase 1, which may lead to treatments for Alzheimer's disease that don't cause harmful side effects. By blocking casein kinase 1, production of beta-amyloid proteins can be reduced without affecting Notch signaling.
A team of researchers at Penn State has discovered a master regulator that controls metabolic responses to essential amino acid deficiency, leading to profound effects on fat metabolism. The discovery may lead to new treatments for obesity and protein malnutrition, particularly in underdeveloped nations where malnutrition is prevalent.
Researchers propose a new model for targeted cancer therapy, suggesting that disruption of cell signaling pathways leads to cell death. This could lead to more effective treatment strategies and personalized cancer treatment.
A study published in the Journal of Biological Chemistry found that signal protein Srcasm can block tumor-promoting molecules in skin cells, potentially leading to targeted gene therapy for certain cancers. By increasing Srcasm levels, researchers may be able to reverse uncontrolled cell growth caused by activated Src kinases.
Researchers at Max Planck Institute for Molecular Genetics in Berlin have explained the molecular principles of cell division control mechanisms. The study found that checkpoint kinases interact with a different category of proteins involved in developing the cell division spindle.
Researchers identified a gene mutation that regulates smooth muscle contraction and blood pressure in rats, leading to hypertension. The study may lead to improved treatments by targeting the proliferation of smooth muscle cells.
Researchers at St. Jude Children's Research Hospital used computer-generated images of enzyme pantothenate kinase to unlock mysteries of antibiotic resistance and rare brain degeneration. The study found that despite differences in enzyme structure, types II and III can perform the same job as type I, leading to antibiotic resistance.
Researchers at Thomas Jefferson University found that blocking Rho kinase activity could be a viable treatment for gastrointestinal disorders such as constipation, anal fissures, and hemorrhoids. The study showed that Rho kinase inhibitors can cause direct smooth muscle relaxation and may provide a new strategy to treat these conditions.
Researchers at Boston Biomedical utilize bioinformatics to study the kinome of Dictyostelium, a model organism revealing unique enzymes involved in cell biology. The study identifies 46 conserved kinases across all organisms, providing insights into fundamental cellular processes.
A team of scientists at Duke University used computer-chemistry techniques to study the docking orientation required for a Cdc25B phosphatase enzyme to activate a cyclin-dependent kinase protein complex. The researchers discovered that specific hot spots on the molecules' surfaces must align precisely for the brief docking to accomplis...
The research discovered the structure of JAK2 kinase, a well-validated drug target for cancer and other disorders. The discovery will enable the development of specific molecules to treat diseases where JAK kinases play a pivotal role, leading to a rapid growth of phase I therapeutics.
The meiotic histone code is a complex process that regulates genetic recombination and chromosome segregation during meiosis. This code involves the dynamic changes of histone modifications on chromosomes.
Researchers at Dartmouth's Geisel School of Medicine have discovered that two kinases, CaMKKα and CaMKKβ, can regulate AMPK independent of LKB1, potentially offering new opportunities for cancer treatment. This finding may also contribute to the development of treatments for type 2 diabetes and obesity.
Researchers investigate estrogen and estrogen-like drugs' ability to protect brain cells after a stroke. Preliminary data suggest that these substances can help traumatized cells survive and encourage stem cell maturation into new brain cells.
A new human kinase gene repository has been established, featuring a comprehensive collection of protein and non-protein kinases. The repository will facilitate high-throughput assays and structural studies of this crucial gene family, which plays key roles in various cellular processes.
The researchers developed a novel molecular reporter system to visualize the activation of protein Src, which plays a key role in cell growth and development. By studying mechanical stimuli on Src activation, they discovered that biochemical signals spread across cells through structural elements like actin filaments and microtubules.
Scientists have identified a potential new treatment for structural heart disease by blocking the activity of a protein called CaM kinase. The findings suggest that inhibiting this protein may prevent or reduce symptoms associated with structural heart disease, including electrical instability and mechanical dysfunction.
UCSF scientists Joseph DeRisi and Kevan Shokat have made significant contributions to understanding infectious diseases like SARS and malaria, and are now working to develop new treatments. Their research focuses on protein kinases, which play a crucial role in cell signaling and disease development.
Researchers at Cornell University have discovered a new DNA enzyme, AIRs kinase, with a shape similar to other members of the riboside kinase family. This finding suggests that proteins may evolve using similar rules, and could lead to the design of laboratory tools for testing anticancer drugs.
A study by University of Iowa researchers reveals that the cystic fibrosis protein CFTR can function as an adenylate kinase enzyme, controlling channel opening without consuming energy. This discovery has broad implications for understanding ABC transporters and their role in genetic diseases.
AstraZeneca scientists have discovered selective and potent inhibitors of Aurora kinase activity that may have potential application in human cancer treatment. New pre-clinical research presents a combination of vascular targeting agents with EGFR tyrosine kinase inhibitors, showing greater anti-tumor activity than either agent alone.
Researchers uncover the critical 'on-switch' enzyme Abl kinase plays a crucial role in activating the pathway preparing receptors on muscle cells to react to nerve impulses. This finding has broad implications for understanding neuromuscular diseases and developing targeted treatments.
Researchers discovered a multi-layered protection mechanism in yeast cells that prevents duplicate genes from causing cancer. The system involves three overlapping controls requiring the reversal of multiple chemical processes before genes can be re-copied.
Researchers have discovered a new protein component that controls calcium entry into cells and activates itself and other proteins, making it a potential new drug target for diseases like cancer and heart conditions. The protein, TRP-PLIK, is present in many tissues and its unique dual function has sparked interest among scientists.
Scientists have developed a novel approach to inhibit protein kinase enzymes, which play a crucial role in triggering cancers, hardening of the arteries, and autoimmune diseases. The researchers' bisubstrate analogs effectively prevent these enzymes from working, offering a promising therapeutic strategy for various diseases.
Researchers have developed a chemically switchable approach to study kinases, crucial for signal transmission in all cells. The technique allows precise experiments to determine the specific function of hundreds of kinases without disrupting overall cell function.
Scientists have developed a chimeric receptor in rice cells that enables the switch on of disease-resistance machinery when exposed to brassinolide, a potent growth-promoting hormone. This breakthrough technique offers a promising approach to understanding plant signaling hormones and receptors.
Researchers found that an enzyme called kinase IV is regulated by another enzyme called phosphatase 2A, which attaches to it and quickly shuts it down. This discovery provides insight into how cells control their activities and offers potential for developing targeted drugs to kill cancer cells or bacteria.
Researchers at UNL have discovered a glycoprotein complex, p67, that correlates directly with cells' resistance to viruses. The team found that encouraging the growth of p67 could be a useful means of preventing viruses from taking over cells' reproductive machinery.